IN8bio, Inc.
INAB
$1.10
-$0.08-6.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.07% | -2.99% | -28.23% | 24.34% | 8.22% |
| Total Depreciation and Amortization | -8.60% | -4.03% | -1.14% | -32.78% | 17.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.22% | -43.60% | 2.75% | -27.54% | 14.92% |
| Change in Net Operating Assets | 129.95% | -148.25% | 276.72% | -55.42% | -161.64% |
| Cash from Operations | 24.30% | -131.28% | 39.30% | 10.26% | -25.78% |
| Capital Expenditure | -2,488.89% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,488.89% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 42.06% | 3.60% | 9.76% | 47.44% | -4.00% |
| Issuance of Common Stock | -- | -- | 1,572.66% | -79.79% | 33.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 112.50% | -- | -- | -- | -- |
| Cash from Financing | 73.85% | -101.05% | 1,769.46% | -81.22% | 35.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.78% | -131.50% | 744.97% | -289.18% | 73.80% |